Botulinum Toxin Type A Induced Trapezius Atrophy: A Case Report
| dc.contributor.author | Surve, Sajid | |
| dc.contributor.author | Koehler, Jonathan | |
| dc.creator | Kramer, Andrew | |
| dc.date.accessioned | 2020-12-14T14:15:33Z | |
| dc.date.available | 2020-12-14T14:15:33Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Botulinum Toxin Type A (Botox) has been well documented for its therapeutic role in managing migraines, contractures, and hyperhidrosis, with rather benign side-effects at therapeutic dosages such as weakness, dizziness and headaches. Although animal models have more extensively demonstrated the dose-dependent side effects such as weight loss, paralytic effects, and muscular atrophy, it has been rarely seen in therapeutic doses clinically in humans. We report a case of severe atrophy of the trapezius muscle in a patient following routine Botox injections for migraine prophylaxis. While cases of botox-induced atrophy have not been well-documented, it is crucial to be aware and prepared for any complications stemming from therapeutic doses of Botulinum toxin. | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12503/30355 | |
| dc.language.iso | en | |
| dc.title | Botulinum Toxin Type A Induced Trapezius Atrophy: A Case Report | |
| dc.type | poster | |
| dc.type.material | text |